Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12619001760167Phase 3Completed
Phase 3, open-label trial of tramadol, parecoxib and lidocaine in pain (3 arms), sponsored by Xenofon Ouzounidis. Primary endpoint: Pain during biopsy procedure. Started Oct 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12619001760167.